KIT and neoplasm: Additionally, the tumor-suppressive effects of KIT-d-MMAE and KIT-d-DM1 were distinctly superior to those of VcMMAE and SMCC-DM1, respectively, indicating that conjugation with the aptamer KIT-d enhances the targeted drug delivery efficacy.